Based on Mindray's new generation ultrasound platform, mQuadro, M9 has raised the industry standards to an all new level. Advanced signal transmission and reception processors provide highly sensitive and accurate echo detection. Innovative transducer technologies allow for better penetration, higher resolution, greatly enhancing your diagnostic experience.
Providing sharper images, all probes compatible with the M9 come equipped with Mindray’s unique 3T transducer technology. Enhanced with the addition of single crystal technology, M9 offers better penetration and color dynamic flow, especially during difficult-patient scanning.
Echo BoostTM
Mindray’s unique adaptive signal processing technology with intelligent echo detection, designed to utilize the native signal-to-noise information to enhance the weak echo signals while suppressing the surrounding clutter noise, providing more balanced image brightness and improved visualization of myocardium tissue layers.
The TT QA functionality on M9 allows for a simple, quick and non-invasive solution for the evaluation of left ventricular wall motion abnormalities. Supported by Mindray’s patented 3T technology with single crystal, M9 significantly improves the tracking accuracy and effectiveness, controlling the image drift caused by the probe movement and respiration. With the added unique benefit of on-site analyses, the TT QA on M9 can be performed at the bed side, saving time and making complicated diagnoses much simpler.
M9’s premium capabilities allow for LV opacification during stress, enhancing discrimination between myocardial tissue and blood pool, providing better visualization of the endocardial surface.